KoreaTechToday - Korea's Leading Tech and Startup Media Platform
  • Topics
    • Naver
    • Kakao
    • Nexon
    • Netmarble
    • NCsoft
    • Samsung
    • Hyundai
    • SKT
    • LG
    • KT
    • Retail
    • Startup
    • Blockchain
    • government
  • Topics
    • Naver
    • Kakao
    • Nexon
    • Netmarble
    • NCsoft
    • Samsung
    • Hyundai
    • SKT
    • LG
    • KT
    • Retail
    • Startup
    • Blockchain
    • government
No Result
View All Result
KoreaTechToday - Korea's Leading Tech and Startup Media Platform
No Result
View All Result
Home Biotech

South Korean Firms to Inject 10 Trillion Won into Biotechnology by 2023

 1,300 total views,  1 views today

James Jung by James Jung
PUBLISHED: November 18, 2020 UPDATED: November 19, 2020
in Biotech, Healthcare, South Korea, Tech Industry
0
President Moon Jae-in giving a speech about the country's biotechnology industry during a signing ceremony held at Yonsei University Global Campus in Songdo, Incheon.
President Moon Jae-in giving a speech about the country's biotechnology industry during a signing ceremony held at Yonsei University Global Campus in Songdo, Incheon. (Yonhap)

President Moon Jae-in giving a speech about the country's biotechnology industry during a signing ceremony held at Yonsei University Global Campus in Songdo, Incheon. (Yonhap)

South Korean biotech companies, including Celltrion and Samsung Biologics, would jointly invest a total of 10 trillion won ($9.03 billion) by 2023 to pursue President Moon Jae-in’s mission to drive economic growth for the country through biotechnology.

Samsung Biologics would invest 1.7 trillion won ($1.54 billion) into its fourth new biopharmaceutical manufacturing plant. Additionally, Celltrion would inject 500 billion won ($447 million) to its Global Life Science Research Lab and third plant.

In return, the government assured a 1.7 trillion won ($1.54 billion) budget for bio-health industries in 2021. The budget marked an increase of 30 percent compared to last year, reflecting the government’s efforts to improve its biologics industry. The total amount of private investments in the bio-health industry would further reach 10 trillion won ($9 billion) in 2023.

Through these investments, Celltrion would grow as the world’s leader in bio drug development and Samsung Biologics as the world’s top contract drug producer.

Supporting Biohealth

President Moon Jae-in participated in the Yonsei University Global Campus ceremony to assure governmental support in the private companies’ endeavors. The event happened in Songdo city, where Samsung Biologics and Celltrion both operate manufacturing plants. The government aims to assist these companies in upgrading their manufacturing and distribution facilities, generating more jobs.

The President thanked Samsung Biologics and Celltrion for their biotech investments as the government searches for new avenues for economic growth. President Moon also congratulated other firms for their reliable investments in the biotechnology industry. Moon stated that 40 biotech companies intend to collectively invest 10 trillion won, which would produce more than 9,000 new jobs.

The country’s annual production of bio drugs would increase to 910,000 from 600,000 liters. South Korea would eventually become a global bio drug manufacturer and the world’s largest biologics substances manufacturer.

Moon also mentioned that the development of vaccines and possible COVID-19 treatments might realize completion by this year’s end.

Kim Tae-han, Samsung Biologics CEO, said that building a fourth plant coincides with President Moon’s initiatives to enhance South Korea’s biopharmaceutical industry. Samsung would support the government’s undertakings in producing COVID-19 treatments and ensuring a stable supply.

Driving Economic Growth

The government selected future-generation vehicles, non-memory chips, and the bio-health industry to drive the economy. The Industry, Science, and Health ministries would unite electronics, semiconductors, data, networks, artificial intelligence, chemicals, energy, and manufacturing with biotechnologies.

The healthcare industry also bears a considerable significance in the wake of the COVID-19 pandemic. The President toured a COVID-19 testing kit producer, SeeGene in March, and the Pasteur Institute in Korea in April, and SK Bioscience in October.

The industry ministry would devote 85.7 billion won to help firms localize their materials, components, and equipment technologies. It would also establish an agency focusing on drug innovation and medical device manufacturing processes.

Furthermore, the government plans to provide education to more than 2,000 biotechnology experts yearly starting from 2024 through academic institutions.

 

Check out other must-read articles from KoreaTechToday:

  • Samsung Biologics to Manufacture Eli Lilly‘s COVID-19 Antibody Treatment
  • Seegene’s COVID-19 PCR Test Kit Receives FDA’s Emergency Approval
  • Hyundai, Naver to Take Lead in President Moon’s Korean “New Deal”
  • President Moon Visits SK hynix Plant, Details Material Industry Plan
What’s your thoughts?
+1
1
+1
0
+1
0
+1
0
+1
0
+1
0
+1
0
Tags: 10 trillion wonbiotechbiotechnologyCelltrionPresident Moon Jae-inSamsung Biologics

Related Posts

South Korea gears up to bring World Expo 2030 to Busan
President Moon Jae-in giving a speech about the country's biotechnology industry during a signing ceremony held at Yonsei University Global Campus in Songdo, Incheon. (Yonhap)
South Korea

South Korea gears up to bring World Expo 2030 to Busan

March 11, 2023
South Korea to commercialize Quantum Cryptography Communications
President Moon Jae-in giving a speech about the country's biotechnology industry during a signing ceremony held at Yonsei University Global Campus in Songdo, Incheon. (Yonhap)
Tech Industry

South Korea to commercialize Quantum Cryptography Communications

March 10, 2023
GC Biopharma to launch first-in-class rare disorder medications in the global market
President Moon Jae-in giving a speech about the country's biotechnology industry during a signing ceremony held at Yonsei University Global Campus in Songdo, Incheon. (Yonhap)
Healthcare

GC Biopharma to launch first-in-class rare disorder medications in the global market

March 2, 2023
South Korea plans Urban Air Mobility Air Taxi services by 2025
President Moon Jae-in giving a speech about the country's biotechnology industry during a signing ceremony held at Yonsei University Global Campus in Songdo, Incheon. (Yonhap)
Tech Industry

South Korea plans Urban Air Mobility Air Taxi services by 2025

February 24, 2023
Samsung headquarters
President Moon Jae-in giving a speech about the country's biotechnology industry during a signing ceremony held at Yonsei University Global Campus in Songdo, Incheon. (Yonhap)
South Korea

Korea’s top 100 companies’ economic contribution soar by 20%  in 9 years

July 20, 2022
South Korea curbs tech leaks to foreign countries
President Moon Jae-in giving a speech about the country's biotechnology industry during a signing ceremony held at Yonsei University Global Campus in Songdo, Incheon. (Yonhap)
South Korea

South Korea curbs tech leaks to foreign countries

February 8, 2022
No Result
View All Result

Follow Us

FREE NEWSLETTER




PRODUCTS

Most Popular

  • 5 Best Korean to English Translation Apps

    0 shares
    Share 0 Tweet 0
  • Top South Korean Tech Products to Look Out for in 2021

    0 shares
    Share 0 Tweet 0
  • Robots to help Police Patrol in South Korea

    0 shares
    Share 0 Tweet 0
  • South Korea plans Urban Air Mobility Air Taxi services by 2025

    0 shares
    Share 0 Tweet 0
  • 5 All-Time Best Rom-Com K-Dramas to Watch

    0 shares
    Share 0 Tweet 0
  • SK On to introduce South Korea’s first LFP Battery Prototype

    0 shares
    Share 0 Tweet 0
  • Outsourcing by Samsung to China Feared by Phone Parts Suppliers

    0 shares
    Share 0 Tweet 0
  • KT Continues to Accelerate Its ‘Digico’ Transformation

    0 shares
    Share 0 Tweet 0
  • South Korea to commercialize Quantum Cryptography Communications

    0 shares
    Share 0 Tweet 0
  • Netmarble subsidiary Metaverse Entertainment’s K-Pop virtual girl band MAVE has a smashing online debut

    0 shares
    Share 0 Tweet 0
  • About Us
  • Account Page
  • application form
  • Cookie policy
  • Default Redirect Page
  • homepage
  • Login
  • login form
  • LogOut
  • Newsletter
  • Privacy Policy
  • Register
  • Reset Password
  • Sample Page
  • Subscription Plan
  • Terms of Use
  • test
  • test
  • testpage
  • TOS Page
  • Visitor Inside User Page

Copyright © 2023 KoreaTechToday | About Us | Terms of Use |Privacy Policy |Cookie Policy| Contact : press@koreatechtoday.com |

No Result
View All Result
  • Topics
    • Naver
    • Kakao
    • Nexon
    • Netmarble
    • NCsoft
    • Samsung
    • Hyundai
    • SKT
    • LG
    • KT
    • Retail
    • Startup
    • Blockchain
    • government

Copyright © 2023 KoreaTechToday | About Us | Terms of Use |Privacy Policy |Cookie Policy| Contact : press@koreatechtoday.com |